1.
Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies.
Leuk Lymphoma
; 64(14): 2333-2337, 2023 Dec.
Article
in English
| MEDLINE
| ID: mdl-37706519